Analysis of Tumor Cell-Specific IgM Antibodies in Sera of CT26 Colon Tumor-Bearing Mice

BF Benjamin Frey
MR Michael Rückert
JW Julia Weber
XM Xaver Mayr
AD Anja Derer
ML Michael Lotter
CB Christoph Bert
FR Franz Rödel
RF Rainer Fietkau
UG Udo S. Gaipl
request Request a Protocol
ask Ask a question
Favorite

For determination of tumor cell-specific IgM antibodies, indirect immunofluorescence analysis was used. Mice sera were thawed on ice and 1 μl of the respective serum sample was co-incubated with 1 × 105 viable CT26 cells for 1 h at 4°C. Thereafter, cells were washed with PBS/10% FBS. The amount of bound antibodies was analyzed by adding staining solution [5.8 μg/ml FITC-conjugated goat anti-mouse IgM (Invitrogen, Darmstadt, Germany)] for 1 h at 4°C in the dark. After washing, cells were resuspended in PBS/10% FBS. Using flow cytometry, the mean fluorescence intensity of CT26 cells per sample was analyzed and equated with the tumor cell-specific IgM antibody level in the serum.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A